Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D<sub>2</sub>-Based Pharmacological Class Effect Query Defined by FAERS.

Hopkins, Seth C; Ogirala, Ajay; Zeni, Courtney; Worden, MaryAlice; Koblan, Kenneth S

Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D₂-Based Pharmacological Class Effect Query Defined by FAERS.

Hopkins, Seth C; Ogirala, Ajay; Zeni, Courtney; Worden, MaryAlice; Koblan, Kenneth S.

Afiliação

Hopkins SC; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA. seth.hopkins@sunovion.com.
Ogirala A; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
Zeni C; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
Worden M; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
Koblan KS; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.

Clin Drug Investig ; 42(12): 1113-1121, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36350559

Assuntos

Doença de Alzheimer; Antipsicóticos; Adolescente; Adulto; Estados Unidos; Humanos; Risperidona/efeitos adversos; Antipsicóticos/efeitos adversos; Dopamina; Olanzapina; United States Food and Drug Administration; Doença de Alzheimer/diagnóstico; Doença de Alzheimer/tratamento farmacológico; Teorema de Bayes; Benzodiazepinas/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Doença de Alzheimer Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Doença de Alzheimer Idioma: En Ano de publicação: 2022 Tipo de documento: Article